
Aurelius Health Group Review
Tirzepatide GLP-1 weight-loss telehealth · Independently scored 6.2/10
Best for: transparent, care-inclusive compounded tirzepatide microdosing
Aurelius Health Group scores below our bar on medical oversight. Read the score breakdown before signing up.
Tirzepatide
then $199/mo ongoing
Price checked on Aurelius Health Group’s site,
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not stated
Coaching
Not stated
No insurance needed · Vetted by our editors
Aurelius Health Group is a telehealth practice built around compounded GLP-1 microdosing, mainly low-dose tirzepatide, rather than standard full-dose therapy, with optional NAD+, L-carnitine, B12 or inositol. Pricing is published and care-inclusive: $89 the first month, then $199 a month covering physician consults, the protocol, monthly check-ins and free shipping. The site itself acknowledges the limited trial data behind microdosing.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
Vetted alternatives to Aurelius Health Group
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology

from $199/mo (microdose plan) · no insurance needed
Aurelius Health Group at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Tirzepatide
- Starting price
- $199/mo (microdose plan) ($89 first month)
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letter on record
How we scored Aurelius Health Group
Each dimension is scored algorithmically from Aurelius Health Group’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
6.1/10At $199/mo (microdose plan), Aurelius Health Group runs about 11% above the $179 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide), with an intro price of $89.
Effectiveness25%
7.2/10Aurelius Health Group offers tirzepatide, which produced the largest average weight loss of any GLP-1 in head-to-head trials.
User Experience15%
6.7/10Online intake and platform experience (consult included in the price); 6 platform features disclosed.
Trust & Safety15%
5.6/10Some details we couldn't independently confirm; no FDA warning letters on file.
Accessibility10%
5.4/10Aurelius Health Group's exact state footprint isn't published. Confirm coverage in your state before signing up.
Support10%
5.2/10Aurelius Health Group provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Aurelius Health Group review
Last checked October 2026- Confirmed current pricing across 1 dose/plan tier
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the provider's public sign-up flow, stopping before payment
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: low.
What we checked
- Provider's own pricing page
- $199/mo across 1 dose/plan tier (checked October 2026)
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with Aurelius Health Group
We walked Aurelius Health Group’s public signup flow in October 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Click Start Your Journey on the homepage, which shows $89 the first month, then $199 a month.
- 2The intake opens on a welcome screen advertising '$110 off your first month' and free shipping; click Get Started.
- 3The 'About you' screen asks for your state, date of birth, sex, height and weight.
- The price is the same everywhere on the site: $89 the first month, then $199 a month.
- The intake says you are 'Charged when you submit' and refunded if treatment is declined, so payment comes before the physician review.
- The state menu lists all 50 states plus DC, but the FAQ says availability is confirmed during intake.
- Cancellation needs 72 hours' notice before the next billing date; the month you cancel in isn't refunded.
- Physician review is promised in under 24 hours; labs and video visits are not mentioned.
- Support is by phone and email; no hours are listed.
Aurelius Health Group customer support
- Phone
- (415) 354-6875
GLP-1 medications Aurelius Health Group offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Peptides Aurelius Health Group offers
Beyond GLP-1s, Aurelius Health Group also offers these peptides. Tap any for our evidence-based guide.
Pricing
Prices re-verified
$89 the first month, then $199 a month for consults, the protocol, check-ins and free shipping. Charged when you submit the intake; refunded if treatment is declined.
Ready to get started?
Plans and promotions change often, so check Aurelius Health Group's current pricing and active discounts before you decide.
What we like
- Simple published price: $89 the first month, then $199 a month
- Monthly physician check-ins, protocol adjustments and secure messaging are included
- Cancel anytime from the patient portal, with no cancellation fee or minimum term
- Full refund if a physician declines treatment
- Free shipping
- Candid that large trials at microdoses are limited
Watch-outs
- Microdose-only program; low doses have thinner trial evidence and likely smaller weight loss than full-dose tirzepatide
- You pay when you submit the intake, before a physician reviews it
- Cancel at least 72 hours before your billing date or you're charged for another month
- No refund for the month you cancel in
- One FAQ answer calls its GLP-1 medications FDA-approved, though compounded versions are not
- No named compounding pharmacy, state list or medical director
- Its LegitScript badge links to a search page rather than a certification seal
Aurelius Health Group: a microdosing bet with plainly published pricing
Aurelius Health Group does something unusual right on its homepage: it admits the thing it sells doesn't have much trial data behind it. The whole program is built around GLP-1 microdosing, mainly a deliberately low dose of the dual GIP/GLP-1 drug tirzepatide, rather than the standard full-dose ladder you'd get on brand-name Mounjaro or Zepbound. If a gentler, lower-intensity protocol with a transparent all-in price appeals to you, Aurelius may suit you. If your main goal is maximum weight loss backed by large clinical trials, this is probably not your provider. Aurelius is unusually upfront about why.
How the pricing works
This is Aurelius's strongest feature, and it beats most compounded brands: the price is fully published, bundled, and care-inclusive. You pay $89 for the first month, and after that the rate steps up to $199 a month (microdose plan). There is no per-dose surcharge, no separate consult fee, and no quiet add-on for monitoring. The subscription covers the physician consultations, the full compounded tirzepatide protocol, the pharmacy shipment, and ongoing check-ins in one number. For comparison, the category median sits around $179 a month, so Aurelius's ongoing rate lands a bit above the middle of the pack once the first-month teaser ends.
How we get the market median: $179 is the middle value of each program's lowest listed ongoing monthly price for compounded semaglutide (month to month, not a first-month promo, a prepaid plan or a price with a membership on top), across the 121 programs that publish one.
Two payment details deserve attention. First, you're charged when you submit the intake, before a physician reviews it. If treatment is declined, you get a full refund. Second, you can cancel anytime with no fee or minimum term. The request must arrive at least 72 hours before your billing date, though, or you pay for another month. The month you cancel in isn't refunded.
What you get: microdosed tirzepatide, plus optional extras
The core product is injectable compounded tirzepatide dosed below the standard therapeutic range. The FAQ says the active drug is typically tirzepatide or semaglutide, but only one price is published. Aurelius frames it as 'dual GIP and GLP-1 receptor activation' at a microdose level. You can layer on optional extras if you want them:
- NAD+: marketed for energy and cellular support
- L-carnitine: often paired with weight-management protocols
- Vitamin B12: a common energy add-on
- Inositol: frequently used for metabolic and PCOS-adjacent support
There is no standard full-dose path. If you start at a microdose and decide you need more, Aurelius isn't structured to take you up the full clinical ladder. You'd have to switch providers, so factor that in before you commit. If room to move up to a standard dose matters more to you, Vela Rx sells regular compounded semaglutide and tirzepatide next to a microdose, at one price for every dose, but it doesn't name its medical group or pharmacy.
Candor about the evidence
Most compounded sellers lean hard on the impressive full-dose trial numbers and let you assume they apply to whatever they're shipping. Aurelius doesn't. The site states plainly that 'large-scale RCT data at sub-therapeutic doses is limited.' That is the most candid line on the page. It's also the right way to read this provider: microdosing has a thinner evidence base than full-dose tirzepatide, and you should expect more modest weight loss as a result. Treat the transparency as a green flag for the company's character, and the caveat itself as a limit on what the protocol can deliver.
Trust, oversight, and what's missing
On the care model, Aurelius checks several boxes, and it runs on a HIPAA-compliant platform. The care model has a clinical wrapper: an initial consultation with a board-certified MD or DO, a 24-hour prescription review, monthly physician check-ins with protocol adjustments, and secure messaging. That's a care-inclusive setup, not a prescription-only mill.
Still, Aurelius leaves more unanswered than it should for a medication you inject, and the gaps are concrete:
- No named compounding pharmacy: Aurelius says only that your protocol ships from 'licensed US compounding pharmacies.' It never names which one, so you can't check that pharmacy's record yourself.
- No published state list: there's no clear roster of where Aurelius can legally treat patients, so confirm your state is covered before paying.
- No named medical director or pharmacist-in-charge: the consults are described as MD/DO-led, but no individual clinical leader is disclosed.
- No LegitScript seal: the footer's 'LegitScript Certified' badge is plain text linking to a general search page, so there's no certification record to check.
- A contradictory FDA answer: one FAQ calls its GLP-1 medications FDA-approved, while another correctly says compounded versions are not.
The legal entity, Aurelius Health, Inc., is named in the terms. Even so, these gaps mean you're trusting the brand's self-description more than you'd like for something you inject weekly. Our scoring methodology weighs these gaps (named pharmacy, state coverage, clinical leadership) heavily for any product taken into the body.
Who it's for, and who should skip it
Consider Aurelius if you specifically want a microdosing protocol, you value a single bundled price with no minimum term, and you appreciate a company that's candid about the evidence limits. The all-in pricing makes it one of the more straightforward compounded options for a low-intensity start.
Skip it if you want the strongest possible weight loss, prefer the option to climb to full therapeutic doses, or need a named pharmacy and a published state list before you'll hand over a card. Skip it too if paying before a physician review bothers you. Those are reasonable requirements, and Aurelius doesn't meet them yet.
Bottom line
Aurelius Health Group is a transparent, care-inclusive way to try compounded tirzepatide microdosing, and its candor about the thin evidence is commendable. But admitting a limitation doesn't erase it. Microdosing likely means smaller results than full-dose therapy, and the unnamed pharmacy, missing state list, unverifiable LegitScript badge and a misleading FDA answer are gaps that matter for an injectable. If a gentle, bundled, low-commitment protocol is what you're after, your state is covered, and you'll mind the 72-hour cancel window, it's a fair pick. If you're chasing the full clinical effect, look elsewhere.
The Bottom Line
Aurelius Health Group scores below our bar on medical oversight. Read the score breakdown before signing up.
Ready to start with Aurelius Health Group?
From $199/mo (microdose plan). See current pricing and start your free consultation.
Aurelius Health Group might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Head-to-head
Compare Aurelius Health Group vs…
Aurelius Health Group scores6.2/10
Side-by-side pricing, medications and scores. Pick a matchup.
Aurelius Health Group vs Amazon One Medical
Amazon One Medical scores 8.5/10

Aurelius Health Group vs Vytora Health
Vytora Health scores 8.4/10
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Aurelius Health Group review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 7.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
See Aurelius Health Group's current pricing
Plans from $199/mo (microdose plan). Start your free consultation to check eligibility and today's price.